Cytidine

Product Details

CAS No:65-46-3

MF:C9H13N3O5

Appearance:white or off-white crystalline powder

Specification:98.5%

UN number:-

Package:1/5/10/25kgs/drum

Supply Capacity:MT

Synonyms:cytidine; 65-46-3; Cytosine riboside; 4-Amino-1-beta-D-ribofuranosyl-2(1H)-pyrimidinone; 1-beta-D-Ribofuranosylcytosine; beta-D-Ribofuranoside, cytosine-1; 1beta-D-Ribofuranosylcytosine; 4-Amino-1beta-D-ribofuranosyl-2(1H)-pyrimidinone; 2(1H)-Pyrimidinone, 4-amino-1-beta-D-ribofuranosyl-; 5CSZ8459RP; CHEBI:17562; DTXSID60891552; 4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one; NSC-20258; 4-amino-1-beta-D-ribofuranosylpyrimidin-2(1H)-one; 4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one; Riboside, Cytosine; Cytosine Ribonucleoside; Ribonucleoside, Cytosine; 4-amino-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)pyrimidin-2-one; 4-amino-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)-1,2-dihydropyrimidin-2-one; RefChem:388908; DTXCID901030645; 200-610-9; 1beta-Ribofuranosylcytosine; 1-beta-Ribofuranosylcytosine; MFCD00006545; Cytidin; Cytosine, 1-beta-D-ribofuranosyl-; 1beta-2'-Ribofuranosylcytosine, d-; NSC 20258; Cyd; 2(1H)-Pyrimidinone, 4-amino-1beta-D-ribofuranosyl-; C9H13N3O5; cytosine-1beta-D-Ribofuranoside; 4-amino-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one; 4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2-one; Cytidine; Cytarabine Impurity E; SMR000058243; 1.beta.-Ribofuranosylcytosine; EINECS 200-610-9; 1.beta.-D-Ribofuranosylcytosine; UNII-5CSZ8459RP; Zytidin; beta-cytidine; .beta.-D-Ribofuranoside, cytosine-1; 3h-cytidine; Cytosine, 1-.beta.-D-ribofuranosyl-; Posilent (TN); CTN; beta.-D-Ribo-C; Cytidine, 99%; 4-Amino-1-|A-D-ribofuranosyl-2(1H)-pyrimidinone; 1-b-D-ribosyl-Cytosine; CYTIDINE [MI]; CP-C; 4-Amino-1.beta.-D-ribofuranosyl-2(1H)-pyrimidinone; CYTIDINE [MART.]; bmse000190; bmse000969; bmse001020; CYTIDINE [WHO-DD]; Epitope ID:141494; 2(1H)-Pyrimidinone, 4-amino-1-.beta.-D-ribofuranosyl-; SCHEMBL7179; 1-b-D-Ribofuranosylcytosine; cytosine-1b-D-Ribofuranoside; beta-D-ribofuranosyl-cytidine; MLS000049947; MLS002207040; 1-beta-D-ribosyl- (6CI); 1-beta-delta-ribosyl-Cytosine; CHEMBL95606; GTPL4728; orb1224329; orb1308081; orb3025725; SCHEMBL8525830; 1-beta-D-ribofuranosyl-Cytosine; cytosine-1b-delta-Ribofuranoside; SCHEMBL17856892; SCHEMBL24781031; SCHEMBL31146639; 1beta-delta-Ribofuranosylcytosine; MSK6801; 1-beta-delta-Ribofuranosylcytosine; Cytidine;Cytarabine EP Impurity E; Cytidine, >=99.0% (HPLC); cytosine-1beta-delta-Ribofuranoside; 1-beta-delta-ribofuranosyl-Cytosine; HY-B0158; EBC-14152; MMV638723; SBB003195; T1591L; AKOS015888568; CCG-266896; CS-1989; DB02097; NC04070; SRI-2352_17; NCGC00093356-08; NCGC00142483-01; NCGC00142483-05; NCGC00142483-09; AS-12696; BP-58628; ST056938; SY005417; DB-029614; NS00069068; C-9850; C00475; D07769; EN300-184125; 1-(beta-D-ribofuranosyl)-4-aminopyrimidin-2-one; 4-Amino-1-b-D-ribofuranosyl-2(1H)-pyrimidinone; Cytosine -D-riboside;Cytosine-1--D-ribofuranoside; F226675; Q422538; 4-Amino-1-|_-D-ribofuranosyl-2(1H)-pyrimidinone; BRD-K71847383-001-07-5; BRD-K71847383-001-12-5; 4-Amino-1-.beta.-D-ribofuranosyl-2-(1H)-pyrimidinone; 4-Amino-1-beta-delta-ribofuranosyl-2(1H)-pyrimidinone; F0348-2240; Z1879263740; 1-(b-D-Ribofuranosyl)-2-oxo-4-amino-1,2-dihydro-1,3-diazine; 6D2DC474-DD76-4081-8B34-10605C218F49; 1-(b-delta-Ribofuranosyl)-2-oxo-4-amino-1,2-dihydro-1,3-diazine; 1-(beta-D-Ribofuranosyl)-2-oxo-4-amino-1,2-dihydro-1,3-diazine; Cytidine, BioReagent, suitable for cell culture, powder, >=99%

Product application:Cytidine,65-46-3,Cytosine riboside,4-Amino-1-beta-D-ribofuranosyl-2(1H)-pyrimidinone,Natural pyrimidine nucleoside,Pharmaceutical grade Cytidine,USP grade cytidine,EP grade cytidine,Citicoline sodium precursor,CDP-choline raw material,Cytidine triphosphate CTP intermediate,Cytarabine intermediate,Gemcitabine starting material,Antiviral nucleoside intermediate,Infant formula nucleotide ingredient,Breast milk nucleotide component,mRNA in vitro transcription raw material,Oligonucleotide synthesis building block,Neuroprotective active ingredient,Food grade cytidine,Cell culture medium additive,High purity Cytidine 99%,Cytidine manufacturer China,CAS 65-46-3 supplier,Suzhou Health Chemicals nucleosides,Cytidine wholesale bulk export

 

Cytidine serves as an indispensable natural pyrimidine nucleoside, vital structural precursor, and versatile metabolic intermediate extensively utilized across the pharmaceutical, infant nutritional formula, neurotherapeutics, and nucleic acid biotechnology sectors. In commercial active pharmaceutical ingredient (API) manufacturing, it functions as the primary and indispensable precursor for the synthesis of major neuroprotective agents, including Citicoline sodium (CDP-choline) and cytidine triphosphate (CTP), which are widely prescribed for ischemic stroke rehabilitation, traumatic brain injury recovery, and cognitive impairment; it also serves as a crucial starting building block for synthesizing frontline antineoplastic and antiviral nucleoside analogues such as Gemcitabine and Cytarabine. In infant formula engineering and specialized medical nutrition, representing one of the most abundant physiological nucleosides in human breast milk, Cytidine is supplemented to accelerate gastrointestinal mucosal maturation, enhance intestinal tight-junction integrity, and support neonatal hepatic lipid metabolism and systemic immune defense. Furthermore, in molecular biology and biopharmaceutical RNA therapeutics, Cytidine is an essential nucleotide monomer for enzymatic in vitro transcription of mRNA vaccines and synthetic oligonucleotides, while serving as a vital nutrient supplement in serum-free cell culture media to maintain robust transcriptional kinetics during recombinant therapeutic protein production.